Kevin B Donnelly
Overview
Explore the profile of Kevin B Donnelly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
26
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kielbasa W, Goldsmith P, Donnelly K, Nuthall H, Shcherbinin S, Fleisher A, et al.
Alzheimers Dement (N Y)
. 2025 Jan;
10(4):e70020.
PMID: 39748851
Introduction: The aggregation and spread of hyperphosphorylated, pathological tau in the human brain is hypothesized to play a key role in Alzheimer's disease (AD) as well as other neurogenerative tauopathies....
2.
Schultze A, Reddy V, Donnelly K, Berridge B
Toxicol Pathol
. 2011 Aug;
39(6):1003-9.
PMID: 21859882
The global practice of drug development is expanding into many different continents and countries. India, in particular, is rapidly emerging as an economic force in this arena by offering ever-expanding...
3.
Donnelly K
Toxicol Pathol
. 2008 May;
36(2):204-17.
PMID: 18474943
Recent voluntary withdrawal of the ergoline-derivative Alzheimers' drug Pergolide (Permax) resulting from demonstrated risk of cardiac valve injury illustrates the increased importance of valve injury in pharmaceutical toxicology. Following the...
4.
Williams T, Donnelly K
Toxicol Pathol
. 2006 Dec;
34(6):738-43.
PMID: 17162531
Since the melanocortin system plays a role in the central control of feeding, melanocortin receptor ligands may be efficacious in treating human obesity. Ten structurally similar melanocortin subtype-4 receptor (MC4R)...
5.
Geiser A, Hummel C, Draper M, Henck J, Cohen I, Rudmann D, et al.
Endocrinology
. 2005 Jul;
146(10):4524-35.
PMID: 16002528
The use of selective estrogen receptor modulators for the treatment of estrogen-dependent diseases in premenopausal women has been hindered by undesirable ovarian stimulation and associated risks of ovarian cysts. We...